Breaking News
Sort by:
Top Post
Taysha Gene Therapies Announces First Patient Dosed with TSHA-102 in the REVEAL Phase 1/2 Trial for the Treatment of Rett Syndrome
Taysha Gene Therapies, a clinical-stage gene therapy company focused on developing and commercializing AAV-based gene […]
Redbud Raises $10M in Series A Round as CRO Focusing on Science-driven Clinical Development
Redbud Medicine, the Delaware-headquartered contract research organization (CRO) announced on Monday following the completion of a series […]
Medable Selected by GSK to Power Decentralized and Hybrid Clinical Trials Across Global Product Portfolio
Medable Inc., the leading software provider for patient-centered clinical trials, today announced that it has […]
Science 37 and NuvoAir Partner to Bring Patient-Centric Experience to Respiratory Clinical Trials
Science 37 Holdings, Inc. (Nasdaq: SNCE), the Agile Clinical Trial Operating System™, today announced a […]
Novo Nordisk to Acquire Forma Therapeutics and Expand Presence in Sickle Cell Disease and Rare Blood Disorders
Novo Nordisk and Forma Therapeutics, Holdings Inc. (Nasdaq: FMTX) today announced that they have entered […]
ObvioHealth Welcomes Scott Dixon as Newest Chief Commercial Officer
ObvioHealth, a leading global virtual research organization (VRO) delivering end-to-end decentralized clinical trials, today announces Scott […]
Digital Rehabilitation Platform Neurofenix Completes $7 Million Series A to Transform Stroke and Brain Injury Recovery
Neurofenix, the neurological rehabilitation platform that uses sensors to improve patient outcomes, has raised $7 million in […]
Castle Creek Biosciences Announces Publication of Preclinical Study for Potential In Vivo Gene Therapy in Nature Communications
Castle Creek Biosciences announced publication of a preclinical study that found that its experimental in vivo gene […]
Novo Holdings Leads $50 Million Investment in MedGenome to Accelerate Expansion Into New Markets and Deepen Product Offerings
MedGenome, the leading genetic diagnostics, research, and data company in South Asia, announced today a […]
Mendus Announces Financing Commitments Totaling Up to SEK 250 Million With Van Herk Investments and Negma Group
Mendus AB (“Mendus” publ; IMMU.ST), a biopharmaceutical company addressing tumor recurrence through cell-based immunotherapies, today announces […]
Bio-Rad Introduces Anti-Evolocumab Antibodies for Use in Preclinical and Clinical Drug Development
Bio-Rad Laboratories, Inc. (NYSE: BIO and BIOb), a global leader in life science research and […]
- Eloxx Pharmaceuticals Announces Final Data Assessment from Phase 2 Combination Clinical Trial of ELX-02 in Class 1 Cystic Fibrosis Patients Read more
- Verge Genomics Announces Positive Safety and Tolerability Data from the Phase 1 Clinical Trial of VRG50635, a Potential Best-in-Class Therapeutic for All Forms of ALS Read more
- DEM BioPharma Appoints Wendy Young, Ph.D., to Scientific Advisory Board Read more
- Confo Therapeutics Enters into Research Collaboration for GPCR-Targeting Antibody Discovery with AbCellera Read more
- Vyriad Announces Expansion of T-Cell Lymphoma Trial at Mayo Clinic Read more